Prophylaxis of Neutropenia with Lipegfilgastrim in Breast Cancer Patients with Dose-Dense Chemotherapy – Results of a non-interventional study on therapeutic routine in Germany (NADENS)
Introduction: Non-interventional study (NIS) on application and effectiveness of primary G-CSF prophylaxis with lipegfilgrastim in primary breast cancer patients undergoing dose dense (dd) or intense dose dense (idd) chemotherapy regimen (CTx) in daily clinical practice.
Methods: Prospective, multi-center, single-arm, NIS in 41 private practices
and 27 hospitals in Germany.
Results: Data analysis of 282 patients with a mean age of 49 years (93.6% of patients
Source: Breast Care - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Germany Health | Hospitals | Study